Advertisement

Topics

ImmunoMet Therapeutics Promotes Benjamin Cowen to CEO

16:14 EST 9 Nov 2017 | Xconomy

Benjamin Cowen, chief operating officer of ImmunoMet Therapeutics, is taking on a new role as CEO of the Houston-based drug developer. Founder and former CEO Sung-Wuk Kim will continue to serve as chairman of the company’s board of directors. Before joining ImmunoMet, Cowen was vice president of corporate development at Milestone Pharmaceuticals. ImmunoMet’s lead drug […]

Original Article: ImmunoMet Therapeutics Promotes Benjamin Cowen to CEO

NEXT ARTICLE

More From BioPortfolio on "ImmunoMet Therapeutics Promotes Benjamin Cowen to CEO"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...